The Role of Compounding Pharmacists During Drug Shortages
Author(s): Ofei Kelvin
Issue: Jul/Aug 2022 - Volume 26, Number 4
View All Articles in Issue
Page(s): 298-301
Download in electronic PDF format for $65
Abstract: Prior to the COVID-19 pandemic, hospitals were already experiencing shortages of key injectable drugs. Unprecedented demand due to large numbers of critically ill patients with COVID-19 contributed to these shortages, especially analgesics, sedatives, and paralytics. Advocacy efforts are successfully creating changes that may improve the current situation. The United States Drug Enforcement Administration tried to combat the shortage situation by increasing annual production quotas of controlled substances necessary for COVID-19 care. This situation was discussed by the United States Drug Enforcement Administration in a press-release dated April 7, 2020. In addition to this, the U.S. Food and Drug Administration has provided guidance to compounding pharmacies, allowing for increased flexibility in the compounding and distribution of drug products. The website for the new guidances can be found within the resources provided in this article.
Related Keywords: Kelvin Ofei, PharmD Candidate, drug shortages, discontinued drugs, supply chain, U.S. Food and Drug Administration, FDA, treatment changes, medication errors, drug safety, adverse drug effects